ABIGO PHARMA A/S — Credit Rating and Financial Key Figures

ABIGO PHARMA A/S (CVR number: 12927983) is a company from ALLERØD. The company reported a net sales of 9.2 mDKK in 2023, demonstrating a decline of -28.7 % compared to the previous year. The operating profit percentage was at 1.2 % (EBIT: 0.1 mDKK), while net earnings were 201.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 4.2 %, which can be considered decent and Return on Equity (ROE) was 4.3 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 81 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ABIGO PHARMA A/S's liquidity measured by quick ratio was 5.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.